Modulation of the cAMP signaling pathway after traumatic brain injury

Experimental Neurology

Volumn 208, Issue 1, 2007, Pages 145-158

  Atkins, Coleen M ^a   Oliva Jr , Anthony A ^a   Alonso, Ofelia F ^a   Pearse, Damien D ^a   Bramlett, Helen M ^a   Dietrich, W Dalton ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

cAMP; Fluid percussion; Inflammation; Interleukin 1 ; Phosphodiesterase; PKA; Rolipram; TBI; TNF ; Traumatic brain injury

Indexed keywords

AMYLOID PRECURSOR PROTEIN; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYTOKINE; INTERLEUKIN 1BETA; PHOSPHODIESTERASE IV INHIBITOR; ROLIPRAM; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AXONAL INJURY; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; HIPPOCAMPUS; HISTOPATHOLOGY; HYDROLYSIS; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; OUTCOME ASSESSMENT; PARIETAL LOBE; PRIORITY JOURNAL; RAT; STATISTICAL SIGNIFICANCE; TRAUMATIC BRAIN INJURY; WESTERN BLOTTING;

AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; BLOTTING, WESTERN; BRAIN INJURIES; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; CYCLIC NUCLEOTIDE PHOSPHODIESTERASES, TYPE 4; ENZYME ACTIVATION; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; INJECTIONS, INTRAPERITONEAL; INTERLEUKIN-1BETA; INTERNAL CAPSULE; MALE; PARIETAL LOBE; PHOSPHODIESTERASE INHIBITORS; RATS; RATS, SPRAGUE-DAWLEY; ROLIPRAM; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA; WOUNDS, NONPENETRATING;

EID: 35348940651     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2007.08.011     Document Type: Article

References (107)

1. Armstead W.M. Role of impaired cAMP and calcium-sensitive K+ channel function in altered cerebral hemodynamics following brain injury. Brain Res. 768 (1997) 177-184
2. Atkins C.M., Chen S., Alonso O.F., Dietrich W.D., and Hu B.R. Activation of calcium/calmodulin-dependent protein kinases after traumatic brain injury. J. Cereb. Blood Flow Metab. 26 (2006) 1507-1518
3. Baer M., Dillner A., Schwartz R.C., Sedon C., Nedospasov S., and Johnson P.F. Tumor necrosis factor-α transcription in macrophages is attenuated by an autocrine factor that preferentially induces NF-κB p50. Mol. Cell. Biol. 18 (1998) 5678-5689
4. Barad M., Bourtchouladze R., Winder D.G., Golan H., and Kandel E. Rolipram, a type IV-specific phosphodiesterase inhibitor, facilitates the establishment of long-lasting long-term potentiation and improves memory. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 15020-15025
5. Bell M.J., Kochanek P.M., Carcillo J.A., Mi Z., Schiding J.K., Wisniewski S.R., Clark R.S., Dixon C.E., Marion D.W., and Jackson E. Interstitial adenosine, inosine, and hypoxanthine are increased after experimental traumatic brain injury in the rat. J. Neurotrauma 15 (1998) 163-170
6. (2+)/CREB/CBP-dependent gene regulation: a shared mechanism critical in long-term synaptic plasticity and neuronal survival. Cell Calcium 34 (2003) 425-430
7. Block F., Tondar A., Schmidt W., and Schwarz M. Delayed treatment with rolipram protects against neuronal damage following global ischemia in rats. Neuroreport 8 (1997) 3829-3832
8. Block F., Bozdag I., and Nolden-Koch M. Inflammation contributes to the postponed ischemic neuronal damage following treatment with a glutamate antagonist in rats. Neurosci. Lett. 298 (2001) 103-106
9. Bramlett H.M., Kraydieh S., Green E.J., and Dietrich W.D. Temporal and regional patterns of axonal damage following traumatic brain injury: A β-amyloid precursor protein immunocytochemical study in rats. J. Neuropathol. Exp. Neurol. 56 (1997) 1132-1141
10. Caggiano A.O., and Kraig R.P. Prostaglandin E receptor subtypes in cultured rat microglia and their role in reducing lipopolysaccharide-induced interleukin-1beta production. J. Neurochem. 72 (1999) 565-575
11. 2+/calmodulin-stimulated enzyme expressed in discrete regions of rat brain. J. Biol. Chem. 269 (1994) 12190-12195
12. Castro A., Jerez M.J., Gil C., and Martinez A. Cyclic nucleotide phosphodiesterases and their role in immunomodulatory responses: advances in the development of specific phosphodiesterase inhibitors. Med. Res. Rev. 25 (2005) 229-244
13. Chen S., Atkins C.M., Liu C.L., Alonso O.F., Dietrich W.D., and Hu B.R. Alterations in mammalian target of rapamycin signaling pathways after traumatic brain injury. J. Cereb. Blood Flow Metab. 27 (2006) 939-949
14. Cho S., Kim Y., Cruz M.O., Park E.M., Chu C.K., Song G.Y., and Joh T.H. Repression of proinflammatory cytokine and inducible nitric oxide synthase (NOS2) gene expression in activated microglia by N-acetyl-O-methyldopamine: protein kinase A-dependent mechanism. Glia 33 (2001) 324-333
15. Ciallella J.R., Ikonomovic M.D., Paljug W.R., Wilbur Y.I., Dixon C.E., Kochanek P.M., Marion D.W., and DeKosky S.T. Changes in expression of amyloid precursor protein and interleukin-1β after experimental traumatic brain injury in rats. J. Neurotrauma 19 (2002) 1555-1567
16. Cogswell J.P., Godlevski M.M., Wisely G.B., Clay W.C., Leesnitzer L.M., Ways J.P., and Gray J.G. NF-kappa B regulates IL-1 beta transcription through a consensus NF-kappa B binding site and a nonconsensus CRE-like site. J. Immunol. 153 (1994) 712-723
17. Dal Piaz V., and Giovannoni M.P. Phosphodiesterase 4 inhibitors, structurally unrelated to rolipram, as promising agents for the treatment of asthma and other pathologies. Eur. J. Med. Chem. 35 (2000) 463-480
18. Dash P.K., Moore A.N., and Dixon C.E. Spatial memory deficits, increased phosphorylation of the transcription factor CREB, and induction of the AP-1 complex following experimental brain injury. J. Neurosci. 15 (1995) 2030-2039
19. de Rooij J., Zwartkruis F.J., Verheijen M.H., Cool R.H., Nijman S.M., Wittinghofer A., and Bos J.L. Epac is a Rap1 guanine-nucleotide-exchange factor directly activated by cyclic AMP. Nature 396 (1998) 474-477
20. Deak M., Clifton A.D., Lucocq L.M., and Alessi D.R. Mitogen- and stress-activated protein kinase-1 (MSK1) is directly activated by MAPK and SAPK2/p38, and may mediate activation of CREB. EMBO J. 17 (1998) 4426-4441
21. Dello Russo C., Boullerne A.I., Gavrilyuk V., and Feinstein D.L. Inhibition of microglial inflammatory responses by norepinephrine: effects on nitric oxide and interleukin-1β production. J. Neuroinflammation 1 (2004) 9-24
22. DeMarch Z., Giampa C., Patassini S., Martorana A., Bernardi G., and Fusco F.R. Beneficial effects of rolipram in a quinolinic acid model of striatal excitotoxicity. Neurobiol. Dis. 25 (2007) 266-273
23. Deogracias R., Espliguero G., Iglesias T., and Rodriguez-Pena A. Expression of the neurotrophin receptor trkB is regulated by the cAMP/CREB pathway in neurons. Mol. Cell. Neurosci. 26 (2004) 470-480
24. Dhillon H.S., Yang L., Padmaperuma B., Dempsey R.J., Fiscus R.R., and Renuka Prasad M. Regional concentrations of cyclic nucleotides after experimental brain injury. J. Neurotrauma 12 (1995) 1035-1043
25. Dietrich W.D., Alonso O., and Halley M. Early microvascular and neuronal consequences of traumatic brain injury: a light and electron microscopic study in rats. J. Neurotrauma 11 (1994) 289-301
26. Dietrich W.D., Chatzipanteli K., Vitarbo E., Wada K., and Kinoshita K. The role of inflammatory processes in the pathophysiology and treatment of brain and spinal cord trauma. Acta Neurochir., Suppl. 89 (2004) 69-74
27. Doppenberg E.M., Choi S.C., and Bullock R. Clinical trials in traumatic brain injury: lessons for the future. J. Neurosurg. Anesthesiol. 16 (2004) 87-94
28. Fan L., Young P.R., Barone F.C., Feuerstein G.Z., Smith D.H., and McIntosh T.K. Experimental brain injury induces differential expression of tumor necrosis factor-α mRNA in the CNS. Brain Res. Mol. Brain Res. 36 (1996) 287-291
29. Ferrendelli J.A., Blank A.C., and Gross R.A. Relationships between seizure activity and cyclic nucleotide levels in brain. Brain Res. 200 (1980) 93-103
30. 45Ca autoradiographic study. Brain Res. 624 (1993) 94-102
31. Foey A.D., Field S., Ahmed S., Jain A., Feldmann M., Brennan F.M., and Williams R. Impact of VIP and cAMP on the regulation of TNF-α and IL-10 production: Implications for rheumatoid arthritis. Arthritis Res. Ther. 5 (2003) R317-R328
32. Folcik V.A., Smith T., O'Bryant S., Kawczak J.A., Zhu B., Sakurai H., Kajiwara A., Staddon J.M., Glabinski A., Chernosky A.L., Tani M., Johnson J.M., Tuohy V.K., Rubin L.L., and Ransohoff R.M. Treatment with BBB022A or rolipram stabilizes the blood-brain barrier in experimental autoimmune encephalomyelitis: an additional mechanism for the therapeutic effect of type IV phosphodiesterase inhibitors. J. Neuroimmunol. 97 (1999) 119-128
33. Freeland K., Boxer L.M., and Latchman D.S. The cyclic AMP response element in the Bcl-2 promoter confers inducibility by hypoxia in neuronal cells. Brain Res. Mol. Brain Res. 92 (2001) 98-106
34. Genain C.P., Roberts T., Davis R.L., Nguyen M.H., Uccelli A., Faulds D., Li Y., Hedgpeth J., and Hauser S.L. Prevention of autoimmune demyelination in non-human primates by a cAMP-specific phosphodiesterase inhibitor. Proc. Natl. Acad. Sci. U. S. A. 92 (1995) 3601-3605
35. Gennarelli T.A. Animate models of human head injury. J. Neurotrauma 11 (1994) 357-368
36. Giorgi M., Modica A., Pompili A., Pacitti C., and Gasbarri A. The induction of cyclic nucleotide phosphodiesterase 4 gene (PDE4D) impairs memory in a water maze task. Behav. Brain Res. 154 (2004) 99-106
37. Gong B., Vitolo O.V., Trinchese F., Liu S., Shelanski M., and Arancio O. Persistent improvement in synaptic and cognitive functions in an Alzheimer mouse model after rolipram treatment. J. Clin. Invest. 114 (2004) 1624-1634
38. Grady M.S., Charleston J.S., Maris D., Witgen B.M., and Lifshitz J. Neuronal and glial cell number in the hippocampus after experimental traumatic brain injury: analysis by stereological estimation. J. Neurotrauma 20 (2003) 929-941
39. Griesbach G.S., Gomez-Pinilla F., and Hovda D.A. The upregulation of plasticity-related proteins following TBI is disrupted with acute voluntary exercise. Brain Res. 1016 (2004) 154-162
40. Griesbach G.S., Hovda D.A., Molteni R., Wu A., and Gomez-Pinilla F. Voluntary exercise following traumatic brain injury: brain-derived neurotrophic factor upregulation and recovery of function. Neuroscience 125 (2004) 129-139
41. Griswold D.E., Webb E.F., Badger A.M., Gorycki P.D., Levandoski P.A., Barnette M.A., Grous M., Christensen S., and Torphy T.J. SB 207499 (Ariflo), a second generation phosphodiesterase 4 inhibitor, reduces tumor necrosis factor α and interleukin-4 production in vivo. J. Pharmacol. Exp. Ther. 287 (1998) 705-711
42. Hicks R.R., Numan S., Dhillon H.S., Prasad M.R., and Seroogy K.B. Alterations in BDNF and NT-3 mRNAs in rat hippocampus after experimental brain trauma. Brain Res. Mol. Brain Res. 48 (1997) 401-406
43. Hosoi R., Ishikawa M., Kobayashi K., Gee A., Yamaguchi M., and Inoue O. Effect of rolipram on muscarinic acetylcholine receptor binding in the intact mouse brain. J. Neural Transm. 110 (2003) 363-372
44. Hou S., Guan H., and Ricciardi R.P. Phosphorylation of serine 337 of NF-κB p50 is critical for DNA binding. J. Biol. Chem. 278 (2003) 45994-45998
45. Houslay M.D., and Adams D.R. PDE4 cAMP phosphodiesterases: modular enzymes that orchestrate signalling cross-talk, desensitization and compartmentalization. Biochem. J. 370 (2003) 1-18
46. Hu S., Peterson P.K., and Chao C.C. Cytokine-mediated neuronal apoptosis. Neurochem. Int. 30 (1997) 427-431
47. Hu B.R., Fux C.M., Martone M.E., Zivin J.A., and Ellisman M.H. Persistent phosphorylation of cyclic AMP responsive element-binding protein and activating transcription factor-2 transcription factors following transient cerebral ischemia in rat brain. Neuroscience 89 (1999) 437-452
48. Hu B., Liu C., Bramlett H., Sick T.J., Alonso O.F., Chen S., and Dietrich W.D. Changes in trkB-ERK1/2-CREB/Elk-1 pathways in hippocampal mossy fiber organization after traumatic brain injury. J. Cereb. Blood Flow Metab. 24 (2004) 934-943
49. Imanishi T., Sawa A., Ichimaru Y., Miyashiro M., Kato S., Yamamoto T., and Ueki S. Ameliorating effects of rolipram on experimentally induced impairments of learning and memory in rodents. Eur. J. Pharmacol. 321 (1997) 273-278
50. Jimenez J.L., Punzon C., Navarro J., Munoz-Fernandez M.A., and Fresno M. Phosphodiesterase 4 inhibitors prevent cytokine secretion by T lymphocytes by inhibiting nuclear factor-κB and nuclear factor of activated T cells activation. J. Pharmacol. Exp. Ther. 299 (2001) 753-759
51. Jin S.L., and Conti M. Induction of the cyclic nucleotide phosphodiesterase PDE4B is essential for LPS-activated TNF-α responses. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 7628-7633
52. Kato H., Araki T., Itoyama Y., and Kogure K. Rolipram, a cyclic AMP-selective phosphodiesterase inhibitor, reduces neuronal damage following cerebral ischemia in the gerbil. Eur. J. Pharmacol. 272 (1995) 107-110
53. Keane R.W., Kraydieh S., Lotocki G., Alonso O.F., Aldana P., and Dietrich W.D. Apoptotic and antiapoptotic mechanisms after traumatic brain injury. J. Cereb. Blood Flow Metab. 21 (2001) 1189-1198
54. Keeling K.L., Hicks R.R., Mahesh J., Billings B.B., and Kotwal G.J. Local neutrophil influx following lateral fluid-percussion brain injury in rats is associated with accumulation of complement activation fragments of the third component (C3) of the complement system. J. Neuroimmunol. 105 (2000) 20-30
55. Keryer G., Yassenko M., Labbe J.C., Castro A., Lohmann S.M., Evain-Brion D., and Tasken K. Mitosis-specific phosphorylation and subcellular redistribution of the RIIα regulatory subunit of cAMP-dependent protein kinase. J. Biol. Chem. 273 (1998) 34594-34602
56. Kinoshita K., Chatzipanteli K., Vitarbo E., Truettner J.S., Alonso O.F., and Dietrich W.D. Interleukin-1β messenger ribonucleic acid and protein levels after fluid-percussion brain injury in rats: importance of injury severity and brain temperature. Neurosurgery 51 (2002) 195-203
57. Kuprash D.V., Udalova I.A., Turetskaya R.L., Rice N.R., and Nedospasov S.A. Conserved κ B element located downstream of the tumor necrosis factor α gene: distinct NF-κ B binding pattern and enhancer activity in LPS activated murine macrophages. Oncogene 11 (1995) 97-106
58. Langlois J.A., Rutland-Brown W., and Thomas K.E. Traumatic Brain Injury in the United States: Emergency Department Visits, Hospitalizations, and Deaths. Centers for Disease Control and Prevention (2004), National Center for Injury Prevention and Control, Atlanta, GA 1-68
59. Lee H.T., Chang Y.C., Wang L.Y., Wang S.T., Huang C.C., and Ho C.J. cAMP response element-binding protein activation in ligation preconditioning in neonatal brain. Ann. Neurol. 56 (2004) 611-623
60. Manganiello V.C., Murata T., Taira M., Belfrage P., and Degerman E. Diversity in cyclic nucleotide phosphodiesterase isoenzyme families. Arch. Biochem. Biophys. 322 (1995) 1-13
61. Martin C., Goggel R., Dal Piaz V., Vergelli C., Giovannoni P., Ernst M., and Uhlig S. Airway relaxant and anti-inflammatory properties of a PDE4 inhibitor with low affinity for the high-affinity rolipram binding site. Naunyn Schmiedebergs Arch. Pharmacol. 365 (2002) 284-289
62. Matsushita Y., Shima K., Nawashiro H., Wada K., Tsuzuki N., and Miyazawa T. Real time monitoring of glutamate following fluid percussion brain injury with hypoxia in the rat. Acta Neurochir. Suppl. 76 (2000) 207-212
63. Mayr B., and Montminy M. Transcriptional regulation by the phosphorylation-dependent factor CREB. Nat. Rev. Mol. Cell Biol. 2 (2001) 599-609
64. Meda L., Cassatella M.A., Szendrei G.I., Otvos Jr. L., Baron P., Villalba M., Ferrari D., and Rossi F. Activation of microglial cells by β-amyloid protein and interferon-γ. Nature 374 (1995) 647-650
65. Meller R., Minami M., Cameron J.A., Impey S., Chen D., Lan J.Q., Henshall D.C., and Simon R.P. CREB-mediated Bcl-2 protein expression after ischemic preconditioning. J. Cereb. Blood Flow Metab. 25 (2005) 234-246
66. Montminy M.R., and Bilezikjian L.M. Binding of a nuclear protein to the cyclic-AMP response element of the somatostatin gene. Nature 328 (1987) 175-178
67. Morganti-Kossmann M.C., Rancan M., Stahel P.F., and Kossmann T. Inflammatory response in acute traumatic brain injury: a double-edged sword. Curr. Opin. Crit. Care 8 (2002) 101-105
68. Muller T., Engels P., and Fozard J.R. Subtypes of the type 4 cAMP phosphodiesterases: structure, regulation and selective inhibition. Trends Pharmacol. Sci. 17 (1996) 294-298
69. Nagakura A., Niimura M., and Takeo S. Effects of a phosphodiesterase IV inhibitor rolipram on microsphere embolism-induced defects in memory function and cerebral cyclic AMP signal transduction system in rats. Br. J. Pharmacol. 135 (2002) 1783-1793
70. Navikas V., Matusevicius D., Soderstrom M., Pirskanen R., Fredrikson S., and Link H. The phosphodiesterase i.v. inhibitor rolipram in vitro reduces the numbers of MBP-reactive IFN-gamma and TNF-alpha mRNA expressing blood mononuclear cells in patients with multiple sclerosis. Clin. Neuropharmacol. 21 (1998) 236-244
71. Nemoz G., Prigent A.F., Moueqqit M., Fougier S., Macovschi O., and Pacheco H. Selective inhibition of one of the cyclic AMP phosphodiesterases from rat brain by the neurotropic compound rolipram. Biochem. Pharmacol. 34 (1985) 2997-3000
72. Nikulina E., Tidwell J.L., Dai H.N., Bregman B.S., and Filbin M.T. The phosphodiesterase inhibitor rolipram delivered after a spinal cord lesion promotes axonal regeneration and functional recovery. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 8786-8790
73. Ollivier V., Parry G.C., Cobb R.R., de Prost D., and Mackman N. Elevated cyclic AMP inhibits NF-kB-mediated transcription in human monocytic cells and endothelial cells. J. Biol. Chem. 271 (1996) 20828-20835
74. 45calcium accumulation following lateral fluid percussion. Neuroscience 128 (2004) 305-322
75. Patrizio M. Tumor necrosis factor reduces cAMP production in rat microglia. Glia 48 (2004) 241-249
76. Pearse D.D., Pereira F.C., Marcillo A.E., Bates M.L., Berrocal Y.A., Filbin M.T., and Bunge M.B. cAMP and Schwann cells promote axonal growth and functional recovery after spinal cord injury. Nat. Med. 10 (2004) 610-616
77. Prabhakar U., Lipshutz D., Bartus J.O., Slivjak M.J., Smith III E.F., Lee J.C., and Esser K.M. Characterization of cAMP-dependent inhibition of LPS-induced TNF α production by rolipram, a specific phosphodiesterase IV (PDE IV) inhibitor. Int. J. Immunopharmacol. 16 (1994) 805-816
78. Prado R., Busto R., and Globus M.Y. Ischemia-induced changes in extracellular levels of striatal cyclic AMP: role of dopamine neurotransmission. J. Neurochem. 59 (1992) 1581-1584
79. Sanderson K.L., Raghupathi R., Saatman K.E., Martin D., Miller G., and McIntosh T.K. Interleukin-1 receptor antagonist attenuates regional neuronal cell death and cognitive dysfunction after experimental brain injury. J. Cereb. Blood Flow Metab. 19 (1999) 1118-1125
80. Sasaki K., and Manabe H. KF19514, a phosphodiesterase 4 and 1 inhibitor, inhibits TNF-α-induced GM-CSF production by a human bronchial epithelial cell line via inhibition of PDE4. Inflamm. Res. 53 (2004) 31-37
81. Sasaki T., Kitagawa K., Omura-Matsuoka E., Todo K., Terasaki Y., Sugiura S., Hatazawa J., Yagita Y., and Hori M. The phosphodiesterase inhibitor rolipram promotes survival of newborn hippocampal neurons after ischemia. Stroke 38 (2007) 1597-1605
82. Scherbel U., Raghupathi R., Nakamura M., Saatman K.E., Trojanowski J.Q., Neugebauer E., Marino M.W., and McIntosh T.K. Differential acute and chronic responses of tumor necrosis factor-deficient mice to experimental brain injury. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 8721-8726
83. Shaywitz A.J., and Greenberg M.E. CREB: A stimulus-induced transcription factor activated by a diverse array of extracellular signals. Ann. Rev. Biochem. 68 (1999) 821-861
84. Shohami E., Novikov M., Bass R., Yamin A., and Gallily R. Closed head injury triggers early production of TNF α and IL-6 by brain tissue. J. Cereb. Blood Flow Metab. 14 (1994) 615-619
85. Si Q., Nakamura Y., Ogata T., Kataoka K., and Schubert P. Differential regulation of microglial activation by propentofylline via cAMP signaling. Brain Res. 812 (1998) 97-104
86. Soares H.D., Hicks R.R., Smith D., and McIntosh T.K. Inflammatory leukocytic recruitment and diffuse neuronal degeneration are separate pathological processes resulting from traumatic brain injury. J. Neurosci. 15 (1995) 8223-8233
87. Souness J.E., and Rao S. Proposal for pharmacologically distinct conformers of PDE4 cyclic AMP phosphodiesterases. Cell. Signal. 9 (1997) 227-236
88. 2+/calmodulin-dependent protein kinase type II and type IV involves phosphorylation of a site that negatively regulates activity. Genes Dev. 8 (1994) 2527-2539
89. Suzuki T., Bramlett H.M., and Dietrich W.D. The importance of gender on the beneficial effects of posttraumatic hypothermia. Exp. Neurol. 184 (2003) 1017-1026
90. Suzuki T., Bramlett H.M., Ruenes G., and Dietrich W.D. The effects of early post-traumatic hyperthermia in female and ovariectomized rats. J. Neurotrauma 21 (2004) 842-853
91. Tabuchi A., Sakaya H., Kisukeda T., Fushiki H., and Tsuda M. Involvement of an upstream stimulatory factor as well as cAMP-responsive element-binding protein in the activation of brain-derived neurotrophic factor gene promoter I. J. Biol. Chem. 277 (2002) 35920-35931
92. Takahashi N., Tetsuka T., Uranishi H., and Okamoto T. Inhibition of the NF-κB transcriptional activity by protein kinase A. Eur. J. Biochem. 269 (2002) 4559-4565
93. Tan Y., Rouse J., Zhang A., Cariati S., Cohen P., and Comb M.J. FGF and stress regulate CREB and ATF-1 via a pathway involving p38 MAP kinase and MAPKAP kinase-2. EMBO J. 15 (1996) 4629-4642
94. Tanaka M., Sotomatsu A., Yoshida T., Hirai S., and Nishida A. Detection of superoxide production by activated microglia using a sensitive and specific chemiluminescence assay and microglia-mediated PC12h cell death. J. Neurochem. 63 (1994) 266-270
95. Taupin V., Toulmond S., Serrano A., Benavides J., and Zavala F. Increase in IL-6, IL-1 and TNF levels in rat brain following traumatic lesion. Influence of pre- and post-traumatic treatment with Ro5 4864, a peripheral-type (p site) benzodiazepine ligand. J. Neuroimmunol. 42 (1993) 177-185
96. Tehranian R., Andell-Jonsson S., Beni S.M., Yatsiv I., Shohami E., Bartfai T., Lundkvist J., and Iverfeldt K. Improved recovery and delayed cytokine induction after closed head injury in mice with central overexpression of the secreted isoform of the interleukin-1 receptor antagonist. J. Neurotrauma 19 (2002) 939-951
97. Thompson H.J., Lifshitz J., Marklund N., Grady M.S., Graham D.I., Hovda D.A., and McIntosh T.K. Lateral fluid percussion brain injury: a 15-year review and evaluation. J. Neurotrauma 22 (2005) 42-75
98. Torphy T.J. Phosphodiesterase isozymes: molecular targets for novel antiasthma agents. Am. J. Respir. Crit. Care Med. 157 (1998) 351-370
99. Truettner J., Schmidt-Kastner R., Busto R., Alonso O.F., Loor J.Y., Dietrich W.D., and Ginsberg M.D. Expression of brain-derived neurotrophic factor, nerve growth factor, and heat shock protein HSP70 following fluid percussion brain injury in rats. J. Neurotrauma 16 (1999) 471-486
100. van Staveren W.C., Markerink-van Ittersum M., Steinbusch H.W., and de Vente J. The effects of phosphodiesterase inhibition on cyclic GMP and cyclic AMP accumulation in the hippocampus of the rat. Brain Res. 888 (2001) 275-286
101. Verghese M.W., McConnell R.T., Strickland A.B., Gooding R.C., Stimpson S.A., Yarnall D.P., Taylor J.D., and Furdon P.J. Differential regulation of human monocyte-derived TNF α and IL-1 β by type IV cAMP-phosphodiesterase (cAMP-PDE) inhibitors. J. Pharmacol. Exp. Ther. 272 (1995) 1313-1320
102. Vitarbo E.A., Chatzipanteli K., Kinoshita K., Truettner J.S., Alonso O.F., and Dietrich W.D. Tumor necrosis factor α expression and protein levels after fluid percussion injury in rats: the effect of injury severity and brain temperature. Neurosurgery 55 (2004) 416-424
103. Witgen B.M., Lifshitz J., Smith M.L., Schwarzbach E., Liang S.L., Grady M.S., and Cohen A.S. Regional hippocampal alteration associated with cognitive deficit following experimental brain injury: a systems, network and cellular evaluation. Neuroscience 133 (2005) 1-15
104. Xing J., Ginty D.D., and Greenberg M.E. Coupling of the RAS-MAPK pathway to gene activation by RSK2, a growth factor-regulated CREB kinase. Science 273 (1996) 959-963
105. Yang K., Perez-Polo J.R., Mu X.S., Yan H.Q., Xue J.J., Iwamoto Y., Liu S.J., Dixon C.E., and Hayes R.L. Increased expression of brain-derived neurotrophic factor but not neurotrophin-3 mRNA in rat brain after cortical impact injury. J. Neurosci. Res. 44 (1996) 157-164
106. Zhang B., Yang L., Konishi Y., Maeda N., Sakanaka M., and Tanaka J. Suppressive effects of phosphodiesterase type IV inhibitors on rat cultured microglial cells: comparison with other types of cAMP-elevating agents. Neuropharm. 42 (2002) 262-269
107. Zhao Y., Zhang H.T., and O'Donnell J.M. Antidepressant-induced increase in high-affinity rolipram binding sites in rat brain: dependence on noradrenergic and serotonergic function. J. Pharmacol. Exp. Ther. 307 (2003) 246-253